Form 4 for CRL Charles River Laboratories
Accepted 2026-01-20 00:00:00 ET · period of report 2025-08-22 · accession 0001100682-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-20 | 2025-08-22 | CRL | LaPlume Joseph W | EVP, Corp Strategy, Develop | S - Sale | $163.72 | -400 | 23.7K | -2% | -$65.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-22 | S | D | 400 | $163.72 | 23,716 | D | — | — |